• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫癌肉瘤:治疗与生存的发病率及趋势

Uterine carcinosarcomas: incidence and trends in management and survival.

作者信息

Arrastia C D, Fruchter R G, Clark M, Maiman M, Remy J C, Macasaet M, Gates E J, Di Maio T, Marzec T

机构信息

Department of Obstetrics and Gynecology, State University of New York-Health Science Center at Brooklyn, 11203, USA.

出版信息

Gynecol Oncol. 1997 Apr;65(1):158-63. doi: 10.1006/gyno.1997.4629.

DOI:10.1006/gyno.1997.4629
PMID:9103406
Abstract

Our study's aim was to determine the incidence of uterine sarcomas in New York City (NYC) and evaluate trends in frequency, treatment, and survival of carcinosarcomas in two Brooklyn hospitals. Population-based cancer registry data for 1976-1985 were used to calculate the incidence of uterine sarcomas in NYC women. Medical records and histology slides of carcinosarcomas at two central Brooklyn hospitals from 1960 to 1995 were reviewed. The incidence of uterine sarcomas in black and white women in NYC was 33.4 and 17.0 per million (P < 0.01). Among 97 women with carcinosarcomas diagnosed in 1960-1995, 75% were diagnosed preoperatively, 82% had a hysterectomy, and 45% of those in clinical stage I were upstaged. Predictors of mortality included the presence of extrauterine extension, deep myometrial invasion, vascular space invasion, and gross residual disease, with only the first two being independent predictors of survival in a multivariate analysis. Adjunctive therapy shifted from radiation in 1960-1969 to cisplatin-based chemotherapy after 1980. In surgical stage III, survival increased significantly between 1960-1979 and 1980-1995, but improvement could not be ascribed to particular therapies. The incidence of uterine sarcomas in black women was twice that in white women. Surgical staging including omentectomy is recommended in the management of carcinosarcomas. Modern medical care may have improved the short-term prognosis of carcinosarcomas.

摘要

我们研究的目的是确定纽约市(NYC)子宫肉瘤的发病率,并评估布鲁克林两家医院中癌肉瘤在发病频率、治疗及生存方面的趋势。利用1976 - 1985年基于人群的癌症登记数据来计算纽约市女性子宫肉瘤的发病率。对布鲁克林两家中心医院1960年至1995年癌肉瘤的病历和组织学切片进行了回顾。纽约市黑人和白人女性子宫肉瘤的发病率分别为每百万人33.4例和17.0例(P < 0.01)。在1960 - 1995年诊断出的97例癌肉瘤女性患者中,75%在术前得到诊断,82%接受了子宫切除术,临床I期患者中有45%出现分期上调。死亡的预测因素包括子宫外扩展、肌层深部浸润、血管间隙浸润和大体残留病灶,在多变量分析中只有前两项是生存的独立预测因素。辅助治疗从1960 - 1969年的放射治疗转变为1980年后基于顺铂的化疗。在手术III期,1960 - 1979年和1980 - 1995年之间生存率显著提高,但改善不能归因于特定治疗。黑人女性子宫肉瘤的发病率是白人女性的两倍。在癌肉瘤的治疗中,建议进行包括大网膜切除术在内的手术分期。现代医疗护理可能改善了癌肉瘤的短期预后。

相似文献

1
Uterine carcinosarcomas: incidence and trends in management and survival.子宫癌肉瘤:治疗与生存的发病率及趋势
Gynecol Oncol. 1997 Apr;65(1):158-63. doi: 10.1006/gyno.1997.4629.
2
Uterine carcinosarcoma and high-risk endometrial carcinomas: a clinicopathological comparison.子宫癌肉瘤与高危子宫内膜癌:临床病理比较
Int J Gynecol Cancer. 2015 May;25(4):629-36. doi: 10.1097/IGC.0000000000000350.
3
Black race independently predicts worse survival in uterine carcinosarcoma.黑人种族独立预测在子宫癌肉瘤中生存率更差。
Gynecol Oncol. 2014 May;133(2):238-41. doi: 10.1016/j.ygyno.2014.02.041. Epub 2014 Mar 6.
4
Retrospective analysis of 80 cases with uterine carcinosarcoma, leiomyosarcoma and endometrial stromal sarcoma in China, 1988-2007.1988 - 2007年中国80例子宫癌肉瘤、平滑肌肉瘤和子宫内膜间质肉瘤的回顾性分析。
Int J Clin Exp Pathol. 2014 Mar 15;7(4):1616-24. eCollection 2014.
5
Is vascular and lymphatic space invasion a main prognostic factor in uterine neoplasms with a sarcomatous component? A retrospective study of prognostic factors of 60 patients stratified by stages.血管和淋巴间隙浸润是伴有肉瘤成分的子宫肿瘤的主要预后因素吗?一项对60例患者按分期分层的预后因素回顾性研究。
Int J Radiat Oncol Biol Phys. 2002 Apr 1;52(5):1320-9. doi: 10.1016/s0360-3016(01)02808-5.
6
Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.伴有肉瘤过度生长的子宫腺肉瘤与子宫癌肉瘤:治疗与生存情况比较
Gynecol Oncol. 2001 Oct;83(1):89-94. doi: 10.1006/gyno.2001.6334.
7
Uterine and ovary carcinosarcomas: outcome, prognosis factors, and adjuvant therapy.子宫和卵巢癌肉瘤:治疗结果、预后因素及辅助治疗
Am J Clin Oncol. 2015 Jun;38(3):272-7. doi: 10.1097/COC.0b013e3182979b27.
8
The role of radiation in improving survival for early-stage carcinosarcoma and leiomyosarcoma.放疗在提高早期癌肉瘤和平滑肌肉瘤生存率方面的作用。
Am J Obstet Gynecol. 2008 Nov;199(5):536.e1-8. doi: 10.1016/j.ajog.2008.04.019. Epub 2008 Jun 3.
9
Survival and risk factors associated with uterine sarcomas and carcinosarcomas in stage I and II.Ⅰ期和Ⅱ期子宫肉瘤及癌肉瘤的生存情况与相关危险因素
Neuro Endocrinol Lett. 2015;36(8):750-7.
10
Uterine Sarcoma: Clinical Presentation, Treatment and Survival Outcomes in Thailand.子宫肉瘤:泰国的临床表现、治疗及生存结果
Asian Pac J Cancer Prev. 2016;17(4):1759-67. doi: 10.7314/apjcp.2016.17.4.1759.

引用本文的文献

1
Updates and controversies in the management of uterine serous carcinoma and uterine carcinosarcoma.子宫浆液性癌和子宫癌肉瘤治疗的进展与争议
Int J Gynecol Cancer. 2025 Mar;35(3):101672. doi: 10.1016/j.ijgc.2025.101672. Epub 2025 Jan 30.
2
Trends in Gynecologic Carcinosarcoma Based on Analysis of the Surveillance Epidemiology End Result (SEER) Database.基于监测、流行病学和最终结果(SEER)数据库分析的妇科癌肉瘤趋势
J Clin Med. 2023 Feb 2;12(3):1188. doi: 10.3390/jcm12031188.
3
Randomized Phase III Trial of Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in Patients With Carcinosarcoma of the Uterus or Ovary: An NRG Oncology Trial.
紫杉醇和卡铂与紫杉醇和异环磷酰胺治疗子宫或卵巢癌肉瘤患者的随机 III 期试验:NRG 肿瘤学试验。
J Clin Oncol. 2022 Mar 20;40(9):968-977. doi: 10.1200/JCO.21.02050. Epub 2022 Jan 10.
4
Carcinosarcoma of the Uterus: A Study From the Surveillance Epidemiology and End Result (SEER) Database.子宫癌肉瘤:来自监测、流行病学和最终结果(SEER)数据库的一项研究
Cureus. 2020 Sep 6;12(9):e10283. doi: 10.7759/cureus.10283.
5
DNA Mismatch Repair-deficient Endometrial Carcinosarcomas Portend Distinct Clinical, Morphologic, and Molecular Features Compared With Traditional Carcinosarcomas.与传统型癌肉瘤相比,存在 DNA 错配修复缺陷的子宫内膜癌肉瘤具有明显不同的临床、形态学和分子特征。
Am J Surg Pathol. 2020 Nov;44(11):1573-1579. doi: 10.1097/PAS.0000000000001561.
6
Trends of uterine carcinosarcoma in the United States.美国子宫癌肉瘤的趋势。
J Gynecol Oncol. 2018 Mar;29(2):e22. doi: 10.3802/jgo.2018.29.e22. Epub 2018 Jan 5.
7
Adjuvant treatment modalities, prognostic predictors and outcomes of uterine carcinosarcomas.子宫癌肉瘤的辅助治疗方式、预后预测因素及结果
Cancer Res Treat. 2015 Apr;47(2):282-9. doi: 10.4143/crt.2014.009. Epub 2014 Sep 4.
8
Eptifibatide induced profound thrombocytopenia in a patient with pelvic malignancy: A case report.依替巴肽致一名盆腔恶性肿瘤患者严重血小板减少症:病例报告
Gynecol Oncol Case Rep. 2012 Mar 14;2(3):75-7. doi: 10.1016/j.gynor.2012.03.002. eCollection 2012.
9
Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma.子宫癌肉瘤手术后的辅助放疗和/或化疗。
Cochrane Database Syst Rev. 2013 Feb 28;2013(2):CD006812. doi: 10.1002/14651858.CD006812.pub3.
10
The influence of adjuvant radiotherapy on patterns of failure and survivals in uterine carcinosarcoma.辅助放疗对子宫癌肉瘤复发模式和生存率的影响。
Radiat Oncol J. 2011 Dec;29(4):228-35. doi: 10.3857/roj.2011.29.4.228. Epub 2011 Dec 28.